← Back to Search

4DCT-Ventilation Imaging for Lung Cancer Preoperative Evaluation

N/A

Waitlist Available

Led By Chad Rusthoven

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient with lung cancer (presumed or biopsy proven) currently undergoing or having undergone evaluation for resection.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up start of study to end of study, up to 2 years

Awards & highlights

Study Summary

This trial looks at whether looking at a person's lungs before surgery can predict how well their lungs will work after surgery.

Who is the study for?

This trial is for men and women aged 18 to 100 with lung cancer, who are being evaluated for lung surgery. They must have a life expectancy over 3 months, agree to follow the study rules, and be available throughout the study. It's not for patients only having a small part of their lung removed (wedge resection).Check my eligibility

What is being tested?

The LIME trial is testing how well a new type of lung imaging called '4DCT-ventilation' can predict lung function after surgery. This could help doctors plan surgeries better by understanding how lungs will work post-operation.See study design

What are the potential side effects?

Since this trial involves imaging rather than medication or invasive procedures, side effects are minimal but may include discomfort during the scan or reactions related to contrast agents if used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am being evaluated for or have had surgery for lung cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ start of study to end of study, up to 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~start of study to end of study, up to 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and start of study to end of study, up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pre-Surgical Imaging and Post-Surgical Lung Function

Secondary outcome measures

Ability of %PPO PFTs

Cost-Effectiveness

Longitudinal Imaging Changes

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: 4DCT-ventilationExperimental Treatment1 Intervention

The patient will undergo 4DCT imaging. The 4DCT imaging data along with image processing techniques will be used to generate a 4DCT-ventilation map. All surgical decisions will be based on the current standard of care imaging (VQ scans) and not on the 4DCT imaging results.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,732 Previous Clinical Trials

2,143,518 Total Patients Enrolled

Chad RusthovenPrincipal InvestigatorUniversity of Colorado, Denver

Bernard JonesPrincipal InvestigatorUniversity of Colorado, Denver

Media Library

4DCT-Ventilation Clinical Trial Eligibility Overview. Trial Name: NCT03426306 — N/A

Lung Cancer Research Study Groups: 4DCT-ventilation

Lung Cancer Clinical Trial 2023: 4DCT-Ventilation Highlights & Side Effects. Trial Name: NCT03426306 — N/A

4DCT-Ventilation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03426306 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies in this research protocol?

"The details on clinicaltrials.gov reveal that enrollment for this medical research is not currently open. The trial was initially posted on March 21st 2018 and last modified 8th of March 2022, but there are 397 other trials recruiting patients at the moment."

Answered by AI

For what type of individuals is this clinical trial appropriate?

"This trial seeks 65 participants afflicted with lung cancer, aged 18 to 100 years old. To be eligible for the study, individuals must demonstrate a willingness to comply with all necessary protocol and have an estimated life expectancy of at least 3 months. Additionally, cardiothoracic surgeons may require applicants to complete a range of pulmonary function tests before they can proceed in the program."

Answered by AI

Does this trial accommodate geriatric participants aged 85 and above?

"Per the requirements outlined on clinicaltrials.gov, individuals between 18 and 100 years old are eligible to apply for this trial. In addition, there are 20 studies targeting minors and 394 trials that exclusively target seniors."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Novel Lung Function Imaging Modality as a Preoperative Evaluation Tool (LIME)

2018. "A Novel Lung Function Imaging Modality as a Preoperative Evaluation Tool (LIME)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03426306.